Metabolic syndrome (MetS) is a cluster of interrelated metabolic disturbances, including central obesity, impaired insulin sensitivity, abnormal lipid levels, and elevated blood pressure (BP), which together contribute to systemic low-grade inflammation and adverse cardiovascular and musculoskeletal outcomes [4,8]. This evidence concerns the gene INS and metabolic syndrome.